US-based IFF has agreed to sell its botanical extracts, vitamins and minerals, natural colours, antioxidants and selected food enhancement activities to SuanNutra.
The businesses generated about $170 million in revenue in 2025, employ around 600 people and operate five plants across Europe, the US and Latin America.
The deal is expected to close by end-2026.
“These businesses are highly respected, and we are confident they will continue to thrive under the ownership of SuanNutra and Carbyne,” said Erik Fyrwald, CEO IFF. “This transaction is another step in optimizing our portfolio and reinforces our focus on our core innovation-led businesses — Taste, Scent and Health & Biosciences — where we see the greatest opportunities to drive long-term profitable growth and create value for our shareholders.”
The transaction includes operations that generated revenues of approximately $170 million in 2025. Collectively, the activities included in the transaction employ about 600 people and operate across five manufacturing facilities in Europe, the United States and Latin America. Financial terms of the deal were not disclosed.
The companies expect to close the sale by the end of 2026, subject to customary closing conditions, including regulatory clearances and the satisfaction of applicable consultation requirements. Alantra acted as financial advisor to IFF and DLA Piper LLP acted as legal counsel.
Note: The headline, insights, and image of this press release may have been refined by the ALCHEMPro staff; the rest of the content remains unchanged.
ALCHEMPro News Desk (MS)
